Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ceftazidime (250mg) + Sulbactam (125mg)
Therapeutic Category
Antibiotic, General and OTC medicines, Antibacterials
Dosage Form
Injection
Packaging Type
Vial + Water
Packaging
375mg
Price
₹55/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Dimezeft 375 Injection combines Ceftazidime, a third-generation cephalosporin antibiotic, with Sulbactam, a beta-lactamase inhibitor. This combination enhances the activity of Ceftazidime by inhibiting bacterial beta-lactamase enzymes, which otherwise degrade the antibiotic. This makes Dimezeft 375 effective against a broader range of bacterial infections, including those caused by resistant organisms. The combination of Ceftazidime and Sulbactam is particularly effective in treating serious infections caused by Gram-negative bacteria, including Pseudomonas aeruginosa, and some Gram-positive bacteria.
Dimezeft 375 is commonly used to treat infections such as pneumonia, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, and sepsis. It is also effective in treating complicated infections in immunocompromised patients. The injection is administered intravenously or intramuscularly, ensuring rapid and targeted antibacterial action.
Common side effects include nausea, diarrhea, rash, injection site reactions, and changes in liver function tests.
Used for the treatment of severe bacterial infections, including respiratory, urinary, intra-abdominal, and skin infections.
Administer only under medical supervision. Complete the full course of treatment to prevent antibiotic resistance.
Store in a cool, dry place at room temperature below 25°C. Protect from light.
Composition : Ceftazidime (250mg)
Composition : Ceftriaxone (1000mg)
Composition : Ceftriaxone (1000mg) + Sulbactam (500mg)
Composition : Ceftriaxone (125mg) Injection
Composition : Ceftriaxone (250mg)
Composition : Ceftriaxone (250mg) + Sulbactam (125mg)
Composition : Ceftriaxone (250mg) + Tazobactum (31.25mg)
Composition : Ceftriaxone (500mg)
Composition : Ceftriaxone (500mg) + Sulbactam (250mg)
Composition : Cefuroxime (1500mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ceftazidime 250mg + Sulbactam 125mg Injection has strong demand in the hospital, anti-infective, and critical care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced injectable antibiotics and institutional healthcare portfolios.
Medical distributors and agencies can benefit from consistent demand for serious bacterial infection management under medical supervision. Ceftazidime 250mg is a third-generation cephalosporin antibiotic with broad-spectrum antibacterial activity Sulbactam 125mg is a beta-lactamase inhibitor that enhances the effectiveness of the antibiotic against resistant bacteria Commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, and hospital-acquired infections Injectable formulation ensures rapid therapeutic action in hospital and clinical settings This strengthens a robust anti-infective and critical care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ceftazidime 250mg + Sulbactam 125mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital demand, institutional procurement opportunities, repeat orders, reliable supply chain support, and attractive margins in the injectable antibiotic segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.